Combination therapy for HIV infection is effective at controlling disease but fails to eradicate the virus because a persistent reservoir of cells harbors latent HIV DNA. In this issue of Cell Host & Microbe, Besnard
et al. (2016) show that the mTOR kinase is essential to reactivate HIV from latency.
